Boehringer Ingelheim sales and marketing update

Boehringer launched Combivent Respimat ipratropium bromide/albuterol inhalation aerosol in the U.S. to treat chronic obstructive pulmonary disease (COPD) patients on an aerosol bronchodilator who con...